MTAC
Income statement / Annual
Last year (2024), MedTech Acquisition Corporation's total revenue was $29.43 M,
and the percentage change from the previous year is not available.
In 2024, MedTech Acquisition Corporation's net income was -$33.23 M.
See MedTech Acquisition Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2024 |
12/31/2022 |
12/31/2021 |
| Operating Revenue |
$29.43 M |
$0.00 |
$0.00 |
| Cost of Revenue |
$4.10 M
|
$0.00
|
$0.00
|
| Gross Profit |
$25.33 M
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0.86
|
0
|
0
|
| Research and Development Expenses |
$17.69 M
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$17.97 M
|
$2.75 M
|
$3.04 M
|
| Selling & Marketing Expenses |
$25.84 M
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$43.81 M
|
$2.75 M
|
$3.04 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$61.49 M
|
$2.75 M
|
$3.04 M
|
| Cost And Expenses |
$65.60 M
|
$2.75 M
|
$3.04 M
|
| Interest Income |
$404.00 K
|
$3.02 M
|
$64.00 K
|
| Interest Expense |
-$3.09 M
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
-$5.84 M
|
-$7.74 M
|
| EBITDA |
-$36.17 M |
-$8.58 M |
-$10.78 M |
| EBITDA Ratio |
-1.23
|
0
|
0
|
| Operating Income Ratio |
-1.23
|
0
|
0
|
| Total Other Income/Expenses Net |
$6.13 M
|
$8.86 M
|
$7.81 M
|
| Income Before Tax |
-$30.04 M
|
$6.11 M
|
$4.77 M
|
| Income Before Tax Ratio |
-1.02
|
0
|
0
|
| Income Tax Expense |
-$6.00 K
|
$570.85 K
|
$0.00
|
| Net Income |
-$33.23 M
|
$5.54 M
|
$4.77 M
|
| Net Income Ratio |
-1.13
|
0
|
0
|
| EPS |
-1.06 |
0.18 |
0.15 |
| EPS Diluted |
-1.06 |
0.18 |
0.15 |
| Weighted Average Shares Out |
$31.25 M
|
$31.25 M
|
$31.25 M
|
| Weighted Average Shares Out Diluted |
$31.25 M
|
$31.25 M
|
$31.25 M
|
| Link |
|
|
|
